Back to today’s briefing

Story perspectives

AstraZeneca's Trixeo Aerosphere: Revolutionizing COPD Treatment Sustainably

5/12/2025

49 8

Summary

Story summary

AstraZeneca's Trixeo Aerosphere, set to launch in late 2025, introduces a groundbreaking propellant, HFO-1234ze(E), boasting a staggering 99.9% reduction in Global Warming Potential compared to traditional inhalers. This innovative COPD treatment not only prioritizes patient health but also aligns with AstraZeneca's commitment to a sustainable, low-carbon future by 2030.

1 of 1

Story summary

AstraZeneca's Trixeo Aerosphere, set to launch in late 2025, introduces a groundbreaking propellant, HFO-1234ze(E), boasting a staggering 99.9% reduction in Global Warming Potential compared to traditional inhalers. This innovative COPD treatment not only prioritizes patient health but also aligns with AstraZeneca's commitment to a sustainable, low-carbon future by 2030.